Evidence map›Paper›PMID 41040954›Full record

ArticleFrontiers in neuroscience2025

Frontal-subcortical dysfunction in toxic oil syndrome: a proof-of-concept eye-tracking and cognitive study four decades after exposure.

Julián Benito-León, José Lapeña-Motilva, Mariano Ruiz-Ortiz, Glen M Doniger, Sonia Álvarez-Sesmero, Verónica Giménez de Béjar, María Antonia Nogales, Montserrat Morales, Ritwick Mondal, Shramana Deb and 3 more

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Julián Benito-LeónDepartment of Neurology, 12 de Octubre University Hospital, Madrid, Spain.
José Lapeña-MotilvaDepartment of Neurology, 12 de Octubre University Hospital, Madrid, Spain.
Mariano Ruiz-OrtizDepartment of Neurology, 12 de Octubre University Hospital, Madrid, Spain.
Glen M DonigerDepartment of Clinical Research, NeuroTrax Corporation, Modiin, Israel.
Sonia Álvarez-SesmeroDepartment of Psychiatry, 12 de Octubre University Hospital, Madrid, Spain.
Verónica Giménez de BéjarDepartment of Neurology, 12 de Octubre University Hospital, Madrid, Spain.
María Antonia NogalesDepartment of Internal Medicine, 12 de Octubre University Hospital, Madrid, Spain.
Montserrat MoralesDepartment of Internal Medicine, 12 de Octubre University Hospital, Madrid, Spain.
Ritwick MondalDepartment of Neurology, Manipal Hospitals, Kolkata, India.
Shramana DebDepartment of Neurology, Manipal Hospitals, Kolkata, India.
Fernando BartoloméGroup of Neurodegenerative Diseases, Hospital Universitario 12 de Octubre Research Institute (imas12), Madrid, Spain.
Carolina AlquézarGroup of Neurodegenerative Diseases, Hospital Universitario 12 de Octubre Research Institute (imas12), Madrid, Spain.
Cecilia García-CenaETSIDI-Center for Automation and Robotics, Universidad Politécnica de Madrid, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Toxic Oil Syndrome (TOS) emerged in Spain in 1981 after ingestion of rapeseed oil adulterated with aniline derivatives. More than four decades later, survivors continue to report cognitive complaints, but objective evidence of long-term dysfunction remains limited. Methods: In this case-control study, 47 TOS survivors and 44 matched healthy controls completed validated eye-tracking paradigms (visually guided, memory-guided, and antisaccade tasks) and a standardized neuropsychological battery. Groups did not differ significantly in age, sex, or education. Results: TOS survivors showed preserved performance on visually guided and memory-guided saccades, with no group differences in latency, gain, peak velocity, or spatial error (all Conclusion: Findings indicate persistent frontal-subcortical circuit dysfunction in TOS survivors, consistent with immune- or vascular-mediated injury patterns rather than progressive neurodegeneration. Eye-tracking provides a noninvasive biomarker of latent executive dysfunction and may be useful for long-term monitoring of populations exposed to environmental toxins.

Indexed as

cognitive impairmenteye-trackerfrontal-subcortical dysfunctionsaccadic eye movementstoxic oil syndrome

Identifiers

PMID41040954
PMCPMC12484009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.